TolerogenixX GmbH

ACTIVE

Germanywww.tolerogenixx.comHolding1–10 employeesEstablished: 2016-01-01

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

50.0%

Trial Status Distribution

Active, not recruiting

25.0%

Recruiting

75.0%

Clinical Trials

Trials sponsored by this organization (4)

A non blinded phase-II study with 3 randomized patient groups of individualized suppression of the patient's immune system with donor modified immune cells (MIC) compared to standard-of-care in kidney transplantation from living donors

Phase 1

Recruiting

interventional

Jul 2024126 participants

Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

Phase 2

Recruiting

interventional

May 2022126 participants

A non blinded phase-II study with 3 randomized patient groups of individualized suppression of the patient's immune system with donor modified immune cells (MIC) compared to standard-of-care in kidney transplantation from living donors

Phase 1

Active, not recruiting

interventional

Jul 2021126 participants

A non blinded phase-II study with 3 randomized patient groups of individualized suppression of the patient's immune system with donor modified immune cells (MIC) compared to standard-of-care in kidney transplantation from living donors

Phase 2

Recruiting

126 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations